Search

Author/Creator Biziotis, Olga-Demetra

1. 167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy. (October 2019)

Authors:
Mekhaeil, Bassem; Zacharidis, Panagiotis; Tsakiridis, Evelyn; Biziotis, Olga-Demetra; Broadfield, Lindsay; Menjolian, Gabe; Mathurin, Tammy; Farrell, Thomas; Muti, Paola; Liu, Stanley; Steinberg, Gregory; Tsakiridis, Theodoros
Journal:
Radiotherapy and oncology
Issue:
Volume 139(2019)Supplement 1
Page Start:
S71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer. (March 2023)

Authors:
Mesci, Aruz; Ahmadi, Elham; Ali, Amr; Gouran-Savadkoohi, Mohammad; Evelyn Tsakiridis, Evangelia; Biziotis, Olga-Demetra; Chow, Tom; Kapoor, Anil; Sur, Monalisa; Steinberg, Gregory R.; Liu, Stanley; Zukotynski, Katherine; Tsakiridis, Theodoros
Journal:
Clinical and translational radiation oncology
Issue:
Volume 39(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy. (October 2019)

Authors:
Biziotis, Olga-Demetra; Tsakiridis, Evangelia - Evelyn; Broadfield, Lindsay; Farrell, Thomas; Menjolian, Gabe; Mathurin, Tammy; Mekhaeil, Bassem; Zacharidis, Panagiotis; Muti, Paola; Abdulkarim, Bassam; Steinberg, Gregory; Tsakiridis, Theodoros
Journal:
Radiotherapy and oncology
Issue:
Volume 139(2019)Supplement 1
Page Start:
S20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗